Miranda Patel

23%
Flag icon
Those contracts “strongly suggest that McKinsey, while representing the FDA, was actively engaging with its private-sector clients that were the targets of this new regulatory process—an obvious conflict of interest,” the letter said.
When McKinsey Comes to Town: The Hidden Influence of the World's Most Powerful Consulting Firm
Rate this book
Clear rating
Open Preview